3McDonald TP. Thrombopoietin: Its biology, clinical aspects, and possibilities [J]. Am J Pediatr Hematol Oncol, 1992,14(1) :8-21.
4Vadhan-Raj S. Recombinant human thro- mbopoietin in myelosuppressive chemo therapy [J]. Oncology ( Williston Park),2001,15(7 Suppl 8):35-8.
5Kuter DJ, Begley CG. Recombinant hu- man thrombopoietin: basic biology and evaluation of clinical studies [J].Blood, 2002,100 (10) : 3457-69.
6Aoe K, Hiraki A,Ueoka H,et al. Significance of thrombocytosis as a useful prognostic indicator in patients with lung cancer [J]. Respiration, 2004, 71 (2) : 170-3.
7Pedersen LM, Milman N. Dianostic significance of platelet count and other blood analyses in patients with lung cancer[J]. Oncol Rep, 2003, 10 ( 1 ): 213-6.
8Estrov Z, Talpaz M, Mavligit G, et al. Elevated plasma thrombopoietic activity in patients with metastatic cancerrelated thrombocytosis[J]. Am J Med, 1995,98(6) :551-8.
